A comprehensive mutation detection assay is described for the entire coding region and all splice site junctions of TP53. The assay is based on denaturing gradient gel electrophoresis, which follows either multiplex polymerase chain reaction (PCR) applied to DNA extracted from fresh or frozen tissue samples or nested PCR applied to DNA extracted from paraffin-embedded tissue samples. in both instances, the analysis can be performed under a single set of conditions. when testing the assay on DNA from cultured lung cancer cell lines and from paraffin-embedded Dukes C colorectal carcinomas, significant TP53 mutations were observed at high frequencies in 15 of 16 lung cancer cell lines (94%) and in 21 of 30 paraffin-embedded tissue samples of D...
p53 mutations are the most common genetic abnormality in humans tumors, but their clinical significa...
BACKGROUND: p53 is commonly inactivated by mutations in the DNA-binding domain in a wide range of ca...
BACKGROUND: p53 is commonly inactivated by mutations in the DNA-binding domain in a wide range of ca...
A comprehensive mutation detection assay is described for the entire coding region and all splice si...
A comprehensive mutation detection assay is described for the entire coding region and all splice si...
A comprehensive mutation detection assay is described for the entire coding region and all splice si...
Colorectal carcinoma is one of the leading cancers in Norway. Molecular profiling of the different s...
Colorectal carcinoma is one of the leading cancers in Norway. Molecular profiling of the different s...
A comprehensive mutation detection assay is presented for the entire coding region and all splice si...
A comprehensive mutation detection assay is presented for the entire coding region and all splice si...
A comprehensive mutation detection assay is presented for the entire coding region and all splice si...
p53 mutations are the most common genetic abnormality in humans tumors, but their clinical significa...
TP53 gene mutations, one of the most common alterations described in human tumors, have also been de...
Introduction:The tumor protein p53 gene (TP53) is a constant target of investigation in cancer patho...
occur in tumor suppressor genes such as p53 and are sporadically located. We describe a homogeneous ...
p53 mutations are the most common genetic abnormality in humans tumors, but their clinical significa...
BACKGROUND: p53 is commonly inactivated by mutations in the DNA-binding domain in a wide range of ca...
BACKGROUND: p53 is commonly inactivated by mutations in the DNA-binding domain in a wide range of ca...
A comprehensive mutation detection assay is described for the entire coding region and all splice si...
A comprehensive mutation detection assay is described for the entire coding region and all splice si...
A comprehensive mutation detection assay is described for the entire coding region and all splice si...
Colorectal carcinoma is one of the leading cancers in Norway. Molecular profiling of the different s...
Colorectal carcinoma is one of the leading cancers in Norway. Molecular profiling of the different s...
A comprehensive mutation detection assay is presented for the entire coding region and all splice si...
A comprehensive mutation detection assay is presented for the entire coding region and all splice si...
A comprehensive mutation detection assay is presented for the entire coding region and all splice si...
p53 mutations are the most common genetic abnormality in humans tumors, but their clinical significa...
TP53 gene mutations, one of the most common alterations described in human tumors, have also been de...
Introduction:The tumor protein p53 gene (TP53) is a constant target of investigation in cancer patho...
occur in tumor suppressor genes such as p53 and are sporadically located. We describe a homogeneous ...
p53 mutations are the most common genetic abnormality in humans tumors, but their clinical significa...
BACKGROUND: p53 is commonly inactivated by mutations in the DNA-binding domain in a wide range of ca...
BACKGROUND: p53 is commonly inactivated by mutations in the DNA-binding domain in a wide range of ca...